Brittany Root
Primary Care · Rock Hill, SCNPI 1639878895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.6% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations.
Across 169 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$795
- GSK$430
- Jazz Pharmaceuticals Inc.$390
- Regeneron Healthcare Solutions, Inc.$230
- Insmed, Inc.$194
- Mylan Specialty L.p.$190
- plus $1K from 16 others
What the payments were for
- Consulting fees$1505%
- Food & beverage$3,00891%
- Education$1615%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $795 |
| GSK | 27 | $430 |
| Jazz Pharmaceuticals Inc. | 17 | $390 |
| Regeneron Healthcare Solutions, Inc. | 10 | $230 |
| Insmed, Inc. | 10 | $194 |
| Mylan Specialty L.p. | 11 | $190 |
| Sanofi | 8 | $163 |
| Viatris Specialty LLC | 9 | $153 |
| Verona Pharma, Inc. | 8 | $148 |
| Inspire Medical Systems, Inc. | 4 | $109 |
| United Therapeutics Corporation | 3 | $88 |
| Boehringer Ingelheim | 4 | $70 |
| Philips North America LLC | 4 | $68 |
| Inogen, Inc. | 4 | $62 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Grifols USA, LLC | 3 | $49 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Resmed Corp | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,319 in reported general payments places this provider in the 85th percentile of 115 primary care providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 215 | $267,638 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 140 | $186,452 |
| Breo ElliptaFluticasone/Vilanterol | 97 | $73,074 |
| Spiriva RespimatTiotropium Bromide | 61 | $68,670 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 55 | $52,409 |
| SymbicortBudesonide/Formoterol Fumarate | 70 | $38,360 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 30 | $30,726 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 85 | $26,967 |
| Incruse ElliptaUmeclidinium Bromide | 29 | $26,055 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 518 | $20,244 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $18,452 |
| Arnuity ElliptaFluticasone Furoate | 32 | $15,955 |
| DuleraMometasone/Formoterol | 21 | $14,711 |
| Wixela InhubFluticasone Propion/Salmeterol | 46 | $10,845 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 31 | $7,624 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $430 | $413,448403 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $795 | $224,812210 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $70 | $139,531136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 115 primary care providers in South Carolina.
Other primary care in Rock Hill
- Sarah TomashefskiGreenville$23K
- Samantha VaughtNorth Myrtle Beach$15K
- Cynthia SmithSeneca$10K
- William ByrdSumter$10K
- Kathleen BoonePawleys Island$9K
- Amanda GroomeGreenville$9K
- Holly SurrencyAiken$8K
- Jessica BoldenAnderson$8K
- Caren ArnetteDillon$7K
- Heather MartinSeneca$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.